Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
IND Approval
Sort By
Newest First
1 / 1
Opioid Conjugate Vaccines
Vaccines Present a Novel Strategy for Opioid Overdose Prevention
Muctarr Sesay, Ph.D.
GBI
PAO-10-022-CL-07
Oct 31, 2022
IND Approval
ActoBio Therapeutics™ Receives IND Green Light for New Antigen-Specific Immunotherapy Study Aimed at Improving Celiac Patients' Tolerance of Gluten
Precigen ActoBio
PR-M09-19-NI-006
Sep 04, 2019
IND Approval
Pulmatrix Receives IND Approval for Pulmazole Phase 2 Clinical Study
Pulmatrix
PR-M02-19-NI-022
Feb 11, 2019
Biosimilars
Innovent Receives IND Approval to Initiate Clinical Trials in China with Sintilimab in Combination with its Biosimilar to Bevacizumab
Innovent
PR-M10-18-NI-056
Oct 17, 2018
1 / 1
